Naturally occurring major and minor capsid protein variants of human papillomavirus 45 (HPV45): Differential recognition by cross-neutralizing antibodies generated by HPV vaccines

Anna Godi, Alessandra Facchetti, Sara L. Bissett, Clementina Cocuzza, Elizabeth Miller, Simon Beddows*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

We investigated naturally occurring variation within the major (L1) and minor (L2) capsid proteins of human papillomavirus genotype 45 (HPV45). Pseudoviruses (PsVs) representing HPV45 sublineages A1, A2, A3, B1, and B2 exhibited comparable particle- to-infectivity ratios and morphologies but demonstrated both increased (A2, A3, and B1) and decreased (B2) sensitivities to cross-neutralization by HPV vaccine antibodies compared to that of the A1 sublineage. Mutant PsVs identified HI loop residue 357 as being critical for conferring this differential sensitivity.

Original languageEnglish
Pages (from-to)3247-3252
Number of pages6
JournalJournal of Virology
Volume90
Issue number6
DOIs
Publication statusPublished - 2016

Bibliographical note

Publisher Copyright:
© 2016, American Society for Microbiology.

Fingerprint

Dive into the research topics of 'Naturally occurring major and minor capsid protein variants of human papillomavirus 45 (HPV45): Differential recognition by cross-neutralizing antibodies generated by HPV vaccines'. Together they form a unique fingerprint.

Cite this